Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2023-03-24
- Last Posted Date
- 2024-02-20
- Target Recruit Count
- 34
- Registration Number
- NCT05784012
- Locations
- 🇪🇸
Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain
🇪🇸Institut Catalá d'Oncologia (ICO) Hospitalet, Hospitalet de Llobregat, Cataluña, Spain
🇪🇸Institut Catalá d'Oncologia (ICO) BADALONA, Badalona, Cataluña, Spain
Spanish Study for Molecular Characterization of Thyroid Carcinoma
- First Posted Date
- 2021-07-21
- Last Posted Date
- 2023-04-20
- Target Recruit Count
- 150
- Registration Number
- NCT04970134
- Locations
- 🇪🇸
Institut Català d'Oncologia Girona - ICO Girona, Girona, Spain
🇪🇸Hospital universitario Marqués de Valdecilla, Santander, Spain
🇪🇸Consorci Corporació Sanitària Parc Taulí de Sabadell, Sabadell, Barcelona, Spain
Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.
- Conditions
- Interventions
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2022-03-23
- Target Recruit Count
- 531
- Registration Number
- NCT04672772
- Locations
- 🇪🇸
Hospital Universitario Canarias (TENERIFE), San Cristobal de la Laguna, Tenerife, Spain
🇪🇸Hospital Universitario Clínico San Carlos, Madrid, Spain
🇪🇸Hospital Regional Universitario de Málaga, Málaga, Andalucia, Spain
Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)
- Conditions
- First Posted Date
- 2020-02-24
- Last Posted Date
- 2024-01-09
- Target Recruit Count
- 141
- Registration Number
- NCT04282109
Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2021-01-07
- Target Recruit Count
- 17
- Registration Number
- NCT03887442
Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer
- First Posted Date
- 2010-12-21
- Last Posted Date
- 2019-04-16
- Target Recruit Count
- 40
- Registration Number
- NCT01264328
- Locations
- 🇪🇸
Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, Spain
🇪🇸Hospital de Navarra, Pamplona, Navarra, Spain
🇪🇸Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx Cancer
- Conditions
- Interventions
- First Posted Date
- 2008-10-02
- Last Posted Date
- 2019-04-11
- Target Recruit Count
- 94
- Registration Number
- NCT00765011
- Locations
- 🇪🇸
Oncogranada, Granada, Spain
🇪🇸Hospital Dr.Josep Trueta (ICO Girona), Girona, Spain
🇪🇸Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona, Spain
TPF Plus Cisplatin and Radiotherapy vs TPF Plus Cetuximab and Radiotherapy to Treat Head and Neck Cancer.
- Conditions
- Interventions
- First Posted Date
- 2008-07-16
- Last Posted Date
- 2019-05-24
- Target Recruit Count
- 519
- Registration Number
- NCT00716391
- Locations
- 🇪🇸
Hospital de Manresa, Manresa, Barcelona, Spain
🇪🇸Hospital Son Llàtzer, Palma De Mallorca, Mallorca, Spain
🇪🇸Hospital Son Dureta, Palma de Mallorca, Mallorca, Spain